<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="hwp">bmjopen</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28988172</article-id><article-id pub-id-type="pmc">5640079</article-id><article-id pub-id-type="publisher-id">bmjopen-2017-016736</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2017-016736</article-id><article-categories><subj-group subj-group-type="heading"><subject>Intensive Care</subject><subj-group><subject>Research</subject></subj-group></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1707</subject></subj-group></article-categories><title-group><article-title>Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial</article-title></title-group><contrib-group><contrib id="author-54423240" contrib-type="author"><name><surname>Heming</surname><given-names>Nicholas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib id="author-54423425" contrib-type="author"><name><surname>Elatrous</surname><given-names>Souheil</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib id="author-41425201" contrib-type="author"><name><surname>Jaber</surname><given-names>Samir</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib id="author-54423447" contrib-type="author"><name><surname>Dumenil</surname><given-names>Anne Sylvie</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib id="author-54423596" contrib-type="author"><name><surname>Cousson</surname><given-names>Jo&#x000eb;l</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib id="author-54423612" contrib-type="author"><name><surname>Forceville</surname><given-names>Xavier</given-names></name><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib id="author-54423628" contrib-type="author"><name><surname>Kimmoun</surname><given-names>Antoine</given-names></name><xref ref-type="aff" rid="aff8">8</xref></contrib><contrib id="author-54423642" contrib-type="author"><name><surname>Trouillet</surname><given-names>Jean Louis</given-names></name><xref ref-type="aff" rid="aff9">9</xref></contrib><contrib id="author-54423660" contrib-type="author"><name><surname>Fichet</surname><given-names>J&#x000e9;r&#x000f4;me</given-names></name><xref ref-type="aff" rid="aff10">10</xref></contrib><contrib id="author-54423677" contrib-type="author"><name><surname>Anguel</surname><given-names>Nadia</given-names></name><xref ref-type="aff" rid="aff11">11</xref></contrib><contrib id="author-53918067" contrib-type="author"><name><surname>Darmon</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff12">12</xref></contrib><contrib id="author-54423720" contrib-type="author"><name><surname>Martin</surname><given-names>Claude</given-names></name><xref ref-type="aff" rid="aff13">13</xref></contrib><contrib id="author-42395443" contrib-type="author"><name><surname>Chevret</surname><given-names>Sylvie</given-names></name><xref ref-type="aff" rid="aff14">14</xref></contrib><contrib id="author-52455946" contrib-type="author"><name><surname>Annane</surname><given-names>Djillali</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><on-behalf-of>for the CRISTAL Investigators</on-behalf-of></contrib-group><aff id="aff1">
<label>1</label>
<institution content-type="department">General Intensive Care Unit</institution>, <institution>Raymond Poincar&#x000e9; Hospital</institution>, <addr-line content-type="city">Garches</addr-line>, <country>France</country>
</aff><aff id="aff2">
<label>2</label>
<institution content-type="department">U1173 Lab Inflammation&#x00026; Infection</institution>, <institution>University of Versailles SQY-Paris Saclay - INSERM</institution>, <addr-line content-type="city">Garches</addr-line>, <country>France</country>
</aff><aff id="aff3">
<label>3</label>
<institution content-type="department">service de r&#x000e9;animation</institution>, <institution>Centre Hospitalo-Universitaire Tahar Sfar, University of Monastir</institution>, <addr-line content-type="city">Mahdia</addr-line>, <country>Tunisia</country>
</aff><aff id="aff4">
<label>4</label>
<institution>Saint Eloi University Hospital</institution>, <addr-line content-type="city">Montpellier</addr-line>, <country>France</country>
</aff><aff id="aff5">
<label>5</label>
<institution>Antoine B&#x000e9;cl&#x000e8;re Hospital</institution>, <addr-line content-type="city">Clamart</addr-line>, <country>France</country>
</aff><aff id="aff6">
<label>6</label>
<institution>Reims University Hospital, Robert Debr&#x000e9; Hospital</institution>, <addr-line content-type="city">Reims</addr-line>, <country>France</country>
</aff><aff id="aff7">
<label>7</label>
<institution>General Hospital</institution>, <addr-line content-type="city">Meaux</addr-line>, <country>France</country>
</aff><aff id="aff8">
<label>8</label>
<institution content-type="department">Intensive Care Unit Brabois</institution>, <institution>Heart and Vessels Institute, Nancy University Hospital</institution>, <addr-line content-type="city">Nancy</addr-line>, <country>France</country>
</aff><aff id="aff9">
<label>9</label>
<institution>Piti&#x000e9; Salp&#x000ea;tri&#x000e8;re Hospital</institution>, <addr-line content-type="city">Paris</addr-line>, <country>France</country>
</aff><aff id="aff10">
<label>10</label>
<institution>Centre Cardiologique du Nord</institution>, <addr-line content-type="city">Saint-Denis</addr-line>, <country>France</country>
</aff><aff id="aff11">
<label>11</label>
<institution>Bic&#x000ea;tre Hospital</institution>, <addr-line content-type="city">Le Kremlin-Bic&#x000ea;tre</addr-line>, <country>France</country>
</aff><aff id="aff12">
<label>12</label>
<institution>Saint Louis Hospital</institution>, <addr-line content-type="city">Paris</addr-line>, <country>France</country>
</aff><aff id="aff13">
<label>13</label>
<institution>AP-HM H&#x000f4;pital Nord</institution>, <addr-line content-type="city">Marseille</addr-line>, <country>France</country>
</aff><aff id="aff14">
<label>14</label>
<institution content-type="department">Biostatistic Team</institution>, <institution>Saint Louis Hospital</institution>, <addr-line content-type="city">Paris</addr-line>, <country>France</country>
</aff><author-notes><corresp><label>Correspondence to</label> Dr Djillali Annane; <email>djillali.annane@aphp.fr</email></corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>6</day><month>10</month><year>2017</year></pub-date><volume>7</volume><issue>10</issue><elocation-id>e016736</elocation-id><history><date date-type="received"><day>06</day><month>3</month><year>2017</year></date><date date-type="rev-recd"><day>30</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjopen-2017-016736.pdf"/><self-uri content-type="reviewers-comments-pdf" xlink:href="bmjopen-2017-016736.reviewer_comments.pdf"/><self-uri content-type="draft-revisions-pdf" xlink:href="bmjopen-2017-016736.draft_revisions.pdf"/><abstract><sec><title>Objective</title><p>To compare the haemodynamic effect of crystalloids and colloids during acute severe hypovolaemic shock.</p></sec><sec><title>Design</title><p>Exploratory subgroup analysis of a multicentre randomised controlled trial (Colloids Versus Crystalloids for the Resuscitation of the Critically Ill, CRISTAL, ClinicalTrials.gov NCT00318942).</p></sec><sec><title>Setting</title><p>CRISTAL was conducted in intensive care units in Europe, North Africa and Canada.</p></sec><sec><title>Participants</title><p>Current analysis included all patients who had a pulmonary artery catheter in place at randomisation. 220 patients (117 received crystalloids vs 103 colloids) underwent pulmonary artery catheterisation.</p></sec><sec><title>Intervention</title><p>Crystalloids versus colloids for fluid resuscitation in hypovolaemic shock.</p></sec><sec><title>Outcome measures</title><p>Haemodynamic data were collected at the time of randomisation and subsequently on days 1, 2, 3, 4, 5, 6 and 7.</p></sec><sec><title>Results</title><p>Median cumulative volume of fluid administered during the first 7 days was higher in the crystalloids group than in the colloids group (3500 (2000&#x02013;6000) vs 2500 (1000&#x02013;4000) mL, p=0.01). Patients in the colloids arm exhibited a lower heart rate over time compared with those allocated to the crystalloids arm (p=0.014). There was no significant difference in Cardiac Index (p=0.053), mean blood pressure (p=0.4), arterial lactates (p=0.9) or global Sequential Organ Failure Assessment score (p=0.3) over time between arms.</p></sec><sec><title>Conclusions</title><p>During acute severe hypovolaemic shock, patients monitored by a pulmonary artery catheter achieved broadly similar haemodynamic outcomes, using lower volumes of colloids than crystalloids. The heart rate was lower in the colloids arm.</p></sec></abstract><kwd-group><kwd>fluid resuscitation</kwd><kwd>intensive care unit (icu)</kwd><kwd>pulmonary artery catheter</kwd><kwd>crystalloid</kwd><kwd>colloid</kwd></kwd-group><funding-group><award-group id="funding-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004571</institution-id><institution>Minist&#x000e8;re des Affaires Sociales et de la Sant&#x000e9;</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Strengths and limitations of this study</title></caption><list list-type="bullet"><list-item><p>Large international multicentre trial, comparing the haemodynamic effect of crystalloids vs colloids in severe hypovolaemic shock. The subgroup analysis met recognised criteria of robustness.</p></list-item><list-item><p>The Colloids Versus Crystalloids for the Resuscitation of the Critically Ill trial was a pragmatic, open label trial.</p></list-item><list-item><p>Pulmonary artery catheter monitoring was left at the patient&#x02019;s physician discretion resulting in missing data.</p></list-item><list-item><p>Results should be considered exploratory.</p></list-item></list></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p>Fluid resuscitation is a cornerstone of the management of hypovolaemia.<xref rid="R1" ref-type="bibr">1</xref> During hypovolaemic shock, fluids restore intravascular volume, cardiac output, oxygen delivery and reverse peripheral hypoperfusion.<xref rid="R2" ref-type="bibr">2</xref> Resuscitation fluids are divided into two distinct categories, crystalloids and colloids.<xref rid="R3" ref-type="bibr">3</xref> On the one hand, crystalloids dilute the plasma protein content, reducing plasma oncotic pressure which may result in interstitial oedema. The most commonly used crystalloid, isotonic saline, induces hyperchloraemic acidosis and acute kidney injury.<xref rid="R4" ref-type="bibr">4&#x02013;6</xref> On the other hand, colloids are composed of large molecules, increasing their vascular retention and are theoretically more effective for fluid resuscitation.<xref rid="R7" ref-type="bibr">7 8</xref> However, the most commonly used colloid, starch, is associated with acute kidney injury, increased need for renal replacement therapy, accumulation in reticuloendothelial tissues and increased requirements for blood products.<xref rid="R9" ref-type="bibr">9&#x02013;11</xref> A series of large clinical trials were recently undertaken aimed at determining which fluid was superior for the resuscitation of critically ill patients.<xref rid="R12" ref-type="bibr">12&#x02013;16</xref>
</p><p>The Colloids Versus Crystalloids for the Resuscitation of the Critically Ill (CRISTAL) trial addressed the issue using a pragmatic approach; rather than studying one fluid versus another, both categories of fluids, crystalloids and colloids, were compared in severe hypovolaemia.<xref rid="R17" ref-type="bibr">17</xref> The CRISTAL trial included 2857 subjects treated in 57 intensive care units (ICUs). The primary outcome, 28-day mortality, did not significantly differ, with 25.4% mortality in the colloids arm vs 27% in the crystalloids arm. This finding was similar to results from previous large trials comparing a single colloid to a single crystalloid.<xref rid="R13" ref-type="bibr">13&#x02013;15</xref> However, mortality by 90 days was significantly lower in the colloids arm than in the crystalloids arm (30.7% vs 34.2%). This finding was deemed exploratory. Additionally, the number of days alive at 7 and 28 days without vasopressor therapy was higher in the colloids than in the crystalloids arm. We sought to compare the effect of crystalloids with that of colloids on haemodynamic parameters during hypovolaemic shock. The pulmonary artery catheter (PAC) provides a reliable and reproducible measure of cardiac output as well as the pulmonary artery pressure, pulmonary artery occlusion pressure (PAOP)&#x000a0;and derived variables.<xref rid="R18" ref-type="bibr">18</xref> Therefore, the current study aimed at assessing the haemodynamic effect of crystalloids vs colloids in the CRISTAL participants monitored by PAC.</p></sec><sec sec-type="methods" id="s2"><title>Materials and methods</title><sec id="s2a"><title>Study setting and patients</title><p>The current study is a subgroup analysis of a randomised multicentre trial (CRISTAL, ClinicalTrials.gov NCT00318942), comparing the effect of crystalloid vs colloid administration for fluid resuscitation in the ICU on mortality at 28 days.<xref rid="R17" ref-type="bibr">17</xref> CRISTAL was a non-blinded, pragmatic study. Included subjects were randomised to receive either crystalloids or colloids for hypovolaemia. Crystalloids consisted of isotonic or hypertonic saline as well as buffered solutions, whereas colloids comprised albumin, gelatins, dextrans and hydroxyethyl starches. Patients were managed throughout their ICU stay with the same fluid category. The type of fluid within the assigned group as well as the amount of fluid to be administered was determined by the physician in charge of the patient, the daily total dose of hydroxyethyl starch being restricted to no more than 30&#x02009;mL/kg of body weight. Physicians could administer albumin in response to demonstrated hypoalbuminaemia.<xref rid="R17" ref-type="bibr">17</xref> The study protocol was approved by local institutional review boards. Deferred informed consent was obtained from participants or legally authorised surrogates.</p><p>For the current ancillary study, among the CRISTAL population, we included all patients who had PAC in place as part of their routine management either prior to or within the first 24&#x02009;hours of randomisation.</p></sec><sec id="s2b"><title>Data collection</title><sec id="s2b1"><title>Demographic and general characteristics</title><p>The following data were prospectively collected at the time of randomisation: age, gender, weight, source of admission, McCabe class<xref rid="R19" ref-type="bibr">19</xref> and Disability Scale Score.<xref rid="R20" ref-type="bibr">20</xref> Severity scores included the Glasgow Coma Scale,<xref rid="R21" ref-type="bibr">21</xref> Simplified Acute Physiology Score II<xref rid="R22" ref-type="bibr">22</xref> and the Sequential Organ Failure Assessment (SOFA) score.<xref rid="R23" ref-type="bibr">23</xref> Causes of acute hypovolaemia were stratified in the initial trial as sepsis, trauma or other disorders. We collected a set of symptoms and biological signs of acute hypovolaemia (online&#x000a0;<xref ref-type="supplementary-material" rid="SP1">supplementary table S1</xref>).</p><supplementary-material content-type="local-data" id="SP1"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp1</object-id><label>Supplementary file 1</label><p>
<inline-supplementary-material id="ss1" xlink:href="bmjopen-2017-016736supp001.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material></sec><sec id="s2b2"><title>Haemodynamic variables</title><p>We prospectively measured, for as long as PAC was in place or up to 7&#x02009;days (whichever occurred first), before randomisation and then once daily (by recording the first value reported in the medical file following the change of shift, ie, typically around 08:00&#x000a0;hours) the following haemodynamic data: heart rate; systolic, diastolic and mean blood pressure; central venous pressure (CVP); systolic, diastolic and mean pulmonary artery pressure; PAOP; Cardiac Index and urinary output. Additionally, mean blood pressure was recorded hourly following the first 24&#x02009;hours after randomisation. We calculated, using standard formulas, the product of the heart rate and systolic blood pressure (or rate&#x02013;pressure product (RPP)), a marker of myocardial perfusion requirement, systemic and pulmonary vascular resistances, Stroke Volume Index&#x000a0;and Left and Right Ventricular Stroke Work Index. Laboratory values included arterial pH, bicarbonate, lactate and mixed venous oxygen saturation (SvO<sub>2</sub>.).&#x000a0;Finally, to compare colloids with crystalloids in reaching the haemodynamic targets of the 6-hour bundles of the Surviving Sepsis Campaign, we collected these same variables 6&#x02009;hours after randomisation.<xref rid="R24" ref-type="bibr">24</xref>
</p></sec><sec id="s2b3"><title>Other variables</title><p>We collected before randomisation and daily up to 7&#x02009;days postrandomisation, the SOFA score and the cumulative volume of administered fluids and throughout the trial the occurrence of the main interventions including packed red cell transfusion and the administration of vasopressors.</p></sec></sec><sec id="s2c"><title>Statistical analysis</title><p>Quantitative variables are expressed as median (IQR) and categorical variables as number (percentage). The 7-day time course of mean, systolic and diastolic blood pressure, CVP, heart rate, Cardiac Index and daily diuresis as well as the results of arterial blood gases was compared between arms. We then compared systolic, diastolic and mean pulmonary artery pressure and PAOP in both arms. In order to further explore differences between arms, we calculated the RPP as well as the various indexes derived from the use of PAC. Mixed effects models, which are appropriate for clustered and dependent data, were used to study the relationship between treatment arms and the time course of haemodynamic variables as well as the global SOFA score.<xref rid="R25" ref-type="bibr">25</xref> The area under the curve of mean blood pressure was estimated for each individual, over the first 24&#x02009;hours, using polynomial integration and compared using the Wilcoxon rank-sum test. Number of days alive without vasopressor therapy was compared using the Wilcoxon rank-sum test. The proportion of patients reversing signs of hypoperfusion (mean blood pressure (MAP)&#x000a0;&#x02265;65&#x02009;mm Hg, urine output&#x000a0;&#x02265;0.5&#x02009;mL/kg/hour, CVP between 8 and 12&#x02009;mm&#x000a0;Hg and SvO<sub>2</sub>&#x000a0;&#x02265;65%, within the first 6&#x02009;hours of resuscitation) in the sepsis subgroup was compared using the Fisher&#x02019;s&#x000a0;exact test.<xref rid="R26" ref-type="bibr">26</xref> Complete case analysis was undertaken. Since the current analysis was deemed exploratory and since we report on all statistical analysis done, no correction for multiples testing was deemed necessary. Statistical analyses were performed using SAS V.9.3 (SAS) and R V.2.13.0 (<ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link>) software. Tests were two sided. A value of p&#x0003c;0.05 was considered significant.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3a"><title>Patients</title><p>Among the CRISTAL population, 220 subjects had PAC in place as part of their routine management, of which 103 received colloids and 117 crystalloids, accounting for a total of 645 catheter-days. PAC was generally in place around the time of randomisation, either before (n=79; 36%) or within 24&#x02009;hours postrandomisation (n=84; 38%). Characteristics of the subgroup of PAC-monitored patients were similar to those of the whole population of the CRISTAL study, regarding age, gender and initial severity scores (<xref ref-type="table" rid="T1">table 1</xref>). Haemodynamic variables at the time of randomisation are described in <xref ref-type="table" rid="T2">table 2</xref>.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Main characteristics at baseline according to randomisation arm</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">All patients <break/>n=220</td><td valign="top" align="left" rowspan="1" colspan="1">Colloids arm <break/>n=103</td><td valign="top" align="left" rowspan="1" colspan="1">Crystalloids arm <break/>n=117</td><td valign="top" align="left" rowspan="1" colspan="1">p Value</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, median (IQR), years</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">68 (57&#x02013;77)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">69 (59&#x02013;79)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">67 (52&#x02013;75)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male sex, no (%)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">141 (64.1)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">71 (68.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">70 (59.8)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.20</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Weight, median (IQR), kg</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">72 (63&#x02013;85)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">71.3 (62.3&#x02013;84.5)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">73.4 (64&#x02013;88)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.49</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Reason for ICU admission, no (%)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="." rowspan="1" colspan="1">0.58</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Medical</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">148 (67.3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">70 (68)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">78 (66.7)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Scheduled surgery</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">41 (18.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">20 (19.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">21 (17.9)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Emergency surgery</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">29 (13.2)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">12 (11.7)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">17 (14.5)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Non-surgical trauma</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2 (0.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1 (1)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1 (0.9)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Source of admission to ICU, no (%)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="." rowspan="1" colspan="1">0.11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Community</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">104 (47.3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">39 (37.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">65 (55.6)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Hospital ward</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">102 (46.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">56 (54.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">46 (39.3)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other ICU</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">11 (5)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">7 (6.8)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">4 (3.4)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Long-term care facility</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">3 (1.3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1 (0.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2 (1.7)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">McCabe class, no (%)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="." rowspan="1" colspan="1">0.83</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No underlying disease or no fatal disease</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">129 (58.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">62 (60.2)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">67 (57.3)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Underlying ultimately fatal disease (&#x0003e;5&#x02009;years)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">83 (37.7)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">38 (36.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">45 (38.5)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Underlying rapidly fatal disease (&#x0003c;1&#x02009;year)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8 (3.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">3 (2.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">5 (4.3)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Knaus Disability Scale, no (%)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="." rowspan="1" colspan="1">0.28</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;A</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">35 (15.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">15 (14.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">20 (17.1)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;B</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">82 (37.3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">33 (32)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">49 (41.9)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;C</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">64 (29.1)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">33 (32)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">31 (26.5)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;D</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">37 (16.8)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">20 (19.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">17 (14.5)</td><td valign="top" align="char" char="." rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Glasgow Coma Scale score, median (IQR)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">11&#x000a0;(3&#x02013;15)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">13&#x000a0;(3&#x02013;15)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">11&#x000a0;(3&#x02013;15)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.61</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SAPS II, median (IQR)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">50 (33&#x02013;65)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">51 (36&#x02013;66)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">50 (30&#x02013;64)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.41</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SOFA, median (IQR)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(5&#x02013;11)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(5&#x02013;11)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">9&#x000a0;(5&#x02013;12)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.80</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sepsis, no (%)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">108 (49.1)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">52 (50.5)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">56 (47.9)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.79</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>Knaus Scale A. prior good health&#x000a0;and no functional limitations; B. mild to moderate limitation of activity owing to chronic medical problem; C. chronic disease producing serious but not incapacitating restriction of activity; D, severe restriction of activity due to disease; includes persons bedridden or institutionalised due to illness.</p></fn><fn id="tblfn2"><p>ICU, intensive care unit; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Physiological values at baseline according to randomisation</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">All patients <break/>n=220</td><td valign="top" align="left" rowspan="1" colspan="1">Colloids arm <break/>n=103</td><td valign="top" align="left" rowspan="1" colspan="1">Crystalloids arm <break/>n=117</td><td valign="top" align="left" rowspan="1" colspan="1">p Value</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Heart rate, median (IQR), beats/min (n=218)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">100 (89&#x02013;120)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">99 (88&#x02013;115)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">103.5 (90&#x02013;124)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.25</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Systolic blood pressure, median (IQR), mm Hg&#x000a0;(n=219)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">92 (76&#x02013;109)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">92.5 (73&#x02013;108)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">91 (80&#x02013;111)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.89</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diastolic blood pressure, median (IQR), mm Hg&#x000a0;(n=181)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">48 (40&#x02013;58)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">47 (37&#x02013;57)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">50 (41&#x02013;58)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.19</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mean blood pressure, median (IQR), mm Hg&#x000a0;(n=184)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">66 (56&#x02013;77)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">64.5 (53&#x02013;75)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">67 (60&#x02013;78)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.21</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central venous pressure, median (IQR), mm Hg&#x000a0;(n=81)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">9&#x000a0;(7&#x02013;12)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">10&#x000a0;(6&#x02013;12)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">9&#x000a0;(7&#x02013;13)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.96</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pulmonary artery systolic pressure, median&#x000a0;(IQR), mm Hg (n=64)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">32 (27&#x02013;39)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">32 (25&#x02013;40)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">32 (27&#x02013;38)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.59</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pulmonary artery diastolic pressure, median (IQR), mm Hg (n=64)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">17&#x000a0;(14&#x02013;22)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">16&#x000a0;(12&#x02013;21)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">18&#x000a0;(15&#x02013;22)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.24</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pulmonary artery mean pressure, median (IQR), mm Hg (n=78)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">22&#x000a0;(17&#x02013;28)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">21&#x000a0;(17&#x02013;28)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">23&#x000a0;(19&#x02013;28)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.51</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pulmonary artery occlusion pressure, median (IQR), mm Hg (n=53)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">12&#x000a0;(8&#x02013;15)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">12&#x000a0;(7&#x02013;15)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">12&#x000a0;(9&#x02013;16)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.30</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cardiac Index, median (IQR), L/min/m<sup>2</sup> (n=75)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2.5 (2&#x02013;3.1)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2.4 (2.2&#x02013;3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2.5 (2&#x02013;3.3)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.94</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Systemic vascular resistance, median (IQR), (dyn&#x000a0;s)/cm<sup>5</sup> (n=49)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">893 (690&#x02013;1208)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">906 (699&#x02013;1146)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">830 (637&#x02013;1238)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.40</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pulmonary vascular resistance, median (IQR), (dyn&#x000a0;s)/cm<sup>5</sup> (n=33)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">170 (121&#x02013;260)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">172 (135&#x02013;343)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0.35&#x000a0;(120&#x02013;230)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stroke Volume Index, median (IQR), mL/m<sup>2</sup> (n=74)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">26&#x000a0;(21&#x02013;34)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">27&#x000a0;(22&#x02013;34)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">24&#x000a0;(20&#x02013;33)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.40</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Left-Ventricular Stroke Work Index, median (IQR), (g&#x000a0;m)/m<sup>2</sup> (n=38)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">20&#x000a0;(14&#x02013;31)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">20&#x000a0;(14&#x02013;33)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">17&#x000a0;(14&#x02013;29)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.73</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Right-Ventricular Stroke Work Index, median (IQR), (g&#x000a0;m)/m<sup>2</sup> (n=52)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">5 (2&#x02013;6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">4&#x000a0;(2&#x02013;5)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">5 (3&#x02013;8)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.12</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pH, median (IQR) (n=196)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">7.34 (7.26&#x02013;7.41)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">7.36 (7.28&#x02013;7.43)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">7.33 (7.22&#x02013;7.40)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.038</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HCO<sub>3<sup>&#x02212;</sup></sub>, median (IQR), mmol/L (n=110)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">20.8 (17.6&#x02013;24.2)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">21.3 (17&#x02013;24.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">20 (18&#x02013;23.6)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.44</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lactate, median (IQR), mmol/L (n=155)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2.3 (1.3&#x02013;4.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2.3 (1.3&#x02013;4.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2.25 (1.4&#x02013;5)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.94</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SvO<sub>2</sub>, median (IQR), % (n=33)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">71&#x000a0;(58&#x02013;80)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">63 (58&#x02013;73)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">74 (57&#x02013;81)</td><td valign="top" align="char" char="." rowspan="1" colspan="1">0.31</td></tr></tbody></table><table-wrap-foot><fn id="tblfn3"><p>SvO<sub>2</sub>, mixed venous oxygen saturation.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Treatment effects on haemodynamic variables</title><p>Median cumulative volume of fluid administered during the first 7 days in the ICU was higher in the crystalloids than in the colloids arm (3500 (2000&#x02013;6000) vs 2500 (1000&#x02013;4000) mL, respectively (p=0.01). The distribution of fluid types within each study arm is displayed in online&#x000a0;<xref ref-type="supplementary-material" rid="SP1">supplementary table S2</xref>. During the first 24&#x02009;hours following randomisation, mean blood pressure did not significantly differ between treatment arm (mean area under the curve 78 (68&#x02013;84) for colloids vs 77 (70&#x02013;84) mm&#x000a0;Hg/hour for crystalloids (p=0.6)). The heart rate was lower in the colloids than in the crystalloids group (p=0.014) (<xref ref-type="fig" rid="F1">figure 1</xref>). Systolic, diastolic and mean blood pressure did not significantly differ between arms (p=0.6, p=0.2&#x02009;and p=0.4, respectively) (online&#x000a0;<xref ref-type="supplementary-material" rid="SP4 SP3 SP11">supplementary figure S1-S3</xref>). Cardiac Index, although the difference was not statistically significant (p=0.053), was higher in patients treated with colloids compared with those treated with crystalloids (<xref ref-type="fig" rid="F2">figure 2</xref>). CVP did not differ between both arms (p=0.9) (online&#x000a0;<xref ref-type="supplementary-material" rid="SP5">supplementary figure&#x000a0;S4</xref>). Subjects in the colloids arm exhibited a lower RPP (p=0.036) (<xref ref-type="fig" rid="F3">figure 3</xref>). Arterial pH, arterial levels of bicarbonate and lactate did not differ between groups (p=0.3, p=0.3&#x02009;and p=0.9, respectively) (online&#x000a0;<xref ref-type="supplementary-material" rid="SP6 SP7 SP8">supplementary figure S5-S7</xref>). SvO<sub>2</sub>, daily urine output (online&#x000a0;<xref ref-type="supplementary-material" rid="SP9">supplementary figure&#x000a0;S8</xref>) and the SOFA score did not differ between both arms (p=0.9, p=0.15&#x02009;and p=0.3, respectively). Haemodynamic stability was reached through a similar use of vasopressors and a similar use of blood transfusion (<xref ref-type="table" rid="T3">table 3</xref>). Other relevant outcomes did not significantly differ between both groups. No serious adverse event&#x000a0; related to PAC placement was reported during the trial.</p><supplementary-material content-type="local-data" id="SP5"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp5</object-id><label>Supplementary file 5</label><p>
<inline-supplementary-material id="ss5" xlink:href="bmjopen-2017-016736supp005.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material><supplementary-material content-type="local-data" id="SP9"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp9</object-id><label>Supplementary file 9</label><p>
<inline-supplementary-material id="ss9" xlink:href="bmjopen-2017-016736supp009.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Box&#x000a0;plot showing heart rate distribution over the first 7&#x02009;days following randomisation in both arms.&#x000a0;The horizontal line in the box indicates the median value, whereas the lines at the top and bottom of the box indicate IQR. Day 0,&#x000a0;day of randomisation.&#x000a0;bpm,&#x000a0;beats/min.</p></caption><graphic xlink:href="bmjopen-2017-016736f01"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Box&#x000a0;plot showing Cardiac Index distribution over the first 7&#x02009;days following randomisation in both arms.&#x000a0;The horizontal line in the box indicates the median value, whereas the lines at the top and bottom of the box indicate IQR. Day 0,&#x000a0;day of randomisation.</p></caption><graphic xlink:href="bmjopen-2017-016736f02"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Box&#x000a0;plot showing the rate&#x02013;pressure product distribution over the first 7&#x02009;days following randomisation in both arms.&#x000a0;The horizontal line in the box indicates the median value, whereas the lines at the top and bottom of the box indicate IQR. Day 0,&#x000a0;day of randomisation.</p></caption><graphic xlink:href="bmjopen-2017-016736f03"/></fig><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Study outcome and blood transfusion by treatment group</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Colloids arm <break/>(n=103)</td><td valign="top" align="left" rowspan="1" colspan="1">Crystalloids arm <break/>(n=117)</td><td valign="top" align="left" rowspan="1" colspan="1">p Value</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of days alive without, median (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Vasopressor therapy within the first 28 days</td><td valign="top" align="left" rowspan="1" colspan="1">18 (0&#x02013;25)</td><td valign="top" align="left" rowspan="1" colspan="1">20 (0&#x02013;24)</td><td valign="top" align="left" rowspan="1" colspan="1">0.98</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Units of packed red cell transfused, median (IQR)</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000a0;(2&#x02013;3)</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000a0;(2&#x02013;4)</td><td valign="top" align="left" rowspan="1" colspan="1">0.59</td></tr></tbody></table></table-wrap><p>Isotonic saline solutions and hydroxyl starches were the most common types of administered fluids, among, respectively crystalloids and colloids groups. We therefore compared the overall time&#x000a0;course of haemodynamic parameters between isotonic saline-treated patients and those treated with hydroxyethyl starches. Treatment with hydroxyethyl starches was associated with a lower heart rate (p=0.023) and a lower RPP (p=0.042) compared with isotonic saline.</p></sec><sec id="s3c"><title>Sepsis subgroup</title><p>Among PAC-monitored patients, 108 subjects were stratified in the sepsis group, of which 52 were allocated to colloids and 56 to crystalloids. We compared the number of patients achieving mean blood pressure levels&#x000a0;&#x02265;65&#x02009;mm Hg and urine output&#x000a0;&#x02265;0.5&#x02009;mL/kg/hour within the first 6&#x02009;hours.<xref rid="R24" ref-type="bibr">24</xref> A total of 35/51 (69%) patients in the crystalloids arm achieved MAP&#x000a0;&#x02265;65&#x02009;mm Hg after 6&#x02009;hours vs 31/47 (66%) in the colloids arm (p=0.8); 25/38 (66%) patients in the crystalloids arm achieved urine output&#x000a0;&#x02265;0.5&#x02009;mL/kg/hour after 6&#x02009;hours vs 17/28 (61%) in the colloids arm (p=0.8). Limited data precluded the analysis of CVP and SvO<sub>2</sub> values during the first 6&#x02009;hours following randomisation.</p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>We found that colloids achieved broadly similar resuscitation goals to crystalloids using lower volumes of administered fluids. Additionally, colloids may exhibit a favourable impact on heart rate and RPP. Colloids did not affect any other haemodynamic endpoints. We found, in patients with sepsis, no evidence for a superiority of colloids over crystalloids in achieving haemodynamic targets of the 6-hour bundle of the Surviving Sepsis Campaign.<xref rid="R24" ref-type="bibr">24</xref> The fact that the mean arterial blood pressure and Cardiac Index did not significantly differ in both groups may be explained by the fact that physicians sought to achieve similar targets in both groups, whether by the administration of fluids, packed red&#x000a0;cell or vasopressors.</p><p>Tachycardia may increase myocardial work, with subsequent excessive myocardial energy expenditure,<xref rid="R27" ref-type="bibr">27</xref> and may be associated with worse outcomes through excessive cardiovascular morbimortality.<xref rid="R28" ref-type="bibr">28 29</xref> Myocardial protection is of particular interest in the ageing population currently common in most ICUs, since it may somewhat relieve cardiovascular mortality.</p><p>The efficacy of fluid resuscitation is determined by the capacity of administered fluids to remain in the intravascular space.<xref rid="R1" ref-type="bibr">1</xref> The superior oncotic pressure of colloids is associated with increased intravascular expansion capacity compared with crystalloids. In order to achieve similar resuscitation goals, compared with colloids, between 20% and 50%&#x02009;more volume of crystalloids should be administered.<xref rid="R12" ref-type="bibr">12 13 17 30</xref> Inflammatory states such as those observed during critical illness are usually associated with endothelial dysfunction, leading to interstitial oedema. Reducing volumes of administered fluids may be of clinical benefit, and a negative fluid balance improved outcome in Acute Respiratory Distress Syndrome, a frequent complication of sepsis.<xref rid="R31" ref-type="bibr">31 32</xref> In septic shock, a positive fluid balance has been associated with a worse outcome.<xref rid="R33" ref-type="bibr">33</xref> However, short-term haemodynamic benefits of fluids may in some cases be offset by long-term deleterious consequences. Indeed, some types of colloids may be unsafe. Starches, the most commonly used colloid, may be associated with increased risk of acute kidney injury and increased need for renal replacement therapy, both in the general ICU population and in sepsis.<xref rid="R12" ref-type="bibr">12 13 16</xref> The daily total volume of hydroxyethyl starch which could not exceed 30&#x02009;mL/kg in the CRISTAL trial led patients having exceeded that limit to subsequently receive albumin or crystalloids. The use of starches has now been restricted in the ICU in Europe and the USA.<xref rid="R34" ref-type="bibr">34 35</xref> The implication is that from a haemodynamic point of view, fluid resuscitation with colloids or crystalloids is broadly equivalent&#x02014;maybe with a slight advantage for colloids&#x02014;although the price of resuscitation using crystalloids would be an increase in the total volume of administered fluids.</p><p>Our findings are similar to those of several of the other major fluid trials. Most trials compared one type of colloid with one type of crystalloid. The Saline versus Albumin Fluid Evaluation&#x000a0;(SAFE)study assessed 4% albumin or 9&#x02030; saline in critically ill patients.<xref rid="R14" ref-type="bibr">14</xref> Albumin administration was associated with a statistically significant lower heart rate on the first day of treatment, although the difference was small. The Albumin Italian Outcome Sepsis&#x000a0;(ALBIOS) study compared 20% albumin (titrated to achieve a serum albumin concentration of over 30&#x02009;g/L) to 9&#x02030; saline in patients suffering from severe sepsis.<xref rid="R15" ref-type="bibr">15</xref> Over the first 7 days after randomisation, patients in the albumin arm experienced lower heart rate and a shorter duration of vasopressor therapy. The Crystalloid versus Hydroxyethyl Starch Trial&#x000a0;(CHEST) trial randomised critically ill patients to receive hydroxyethyl starches or 9&#x02030; saline.<xref rid="R13" ref-type="bibr">13</xref> Among the various haemodynamic targets, higher CVP over the first 4&#x02009;days following randomisation was the only statistically significant difference between hydroxyethyl starches and 9&#x02030; saline-treated patients. The authors of the CHEST study concluded that crystalloids were as effective as colloids for initial resuscitation. The Scandinavian Starch for Severe Sepsis/Septic Shock&#x000a0;(6S) trial allocated either hydroxyethyl starches or Ringer&#x02019;s acetate to severe sepsis patients.<xref rid="R12" ref-type="bibr">12</xref> The haemodynamic targets were similar between both arms over the first 24&#x02009;hours after randomisation. Of note, subjects enrolled in both CHEST and 6S studies were enrolled up to 24&#x02009;hours after their admission to the ICU, hence after the initial resuscitation phase. However, in CRISTAL, patients were randomised and treated as early as possible after the occurrence of shock. Patients in CRISTAL were treated by a variety of colloids including starches, but also gelatins, in approximately one-third of patients. Gelatins have been less extensively studied in large clinical trials, and their drawbacks are not as well characterised. Their use may have somewhat offset any deleterious effect related to starches when administered in the colloid group. Overall, these findings should help expand our knowledge pertaining to the field of fluid resuscitation.</p><p>Our study has some limitations. First, our subgroup accounts for less than 10% of the global CRISTAL trial population; the small size of our subgroup is related to a steady decline in the use of the PAC during the CRISTAL trial, amidst reports that the use of PAC does not alter outcome in ICU patients and increased availability of less invasive haemodynamic monitoring tools. Moreover, some selection bias may have been introduced, owing to the fact that PA catheterisation was not performed within 24&#x02009;hours of randomisation in about one-fourth of the sample. Complete case analyses performed on available measurements further assume that missing mechanisms were unrelated to patient status. Finally, some inflation of type I error rate associated with the number of tests undertaken is possible, meaning that interpretation of results should be exploratory.</p></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>CRISTAL participants monitored by a PAC reached broadly similar haemodynamic outcomes whether treated by crystalloids or by colloids. Colloids were associated with lower heart rates and lower volume of administered fluids than crystalloids.</p><supplementary-material content-type="local-data" id="SP3"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp3</object-id><label>Supplementary file 3</label><p>
<inline-supplementary-material id="ss3" xlink:href="bmjopen-2017-016736supp003.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material><supplementary-material content-type="local-data" id="SP4"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp4</object-id><label>Supplementary file 4</label><p>
<inline-supplementary-material id="ss4" xlink:href="bmjopen-2017-016736supp004.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material><supplementary-material content-type="local-data" id="SP6"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp6</object-id><label>Supplementary file 6</label><p>
<inline-supplementary-material id="ss6" xlink:href="bmjopen-2017-016736supp006.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material><supplementary-material content-type="local-data" id="SP7"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp7</object-id><label>Supplementary file 7</label><p>
<inline-supplementary-material id="ss7" xlink:href="bmjopen-2017-016736supp007.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material><supplementary-material content-type="local-data" id="SP8"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp8</object-id><label>Supplementary file 8</label><p>
<inline-supplementary-material id="ss8" xlink:href="bmjopen-2017-016736supp008.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material><supplementary-material content-type="local-data" id="SP11"><object-id pub-id-type="doi">10.1136/bmjopen-2017-016736.supp11</object-id><label>Supplementary file 11</label><p>
<inline-supplementary-material id="ss11" xlink:href="bmjopen-2017-016736supp011.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="d35e431" content-type="local-data"><caption><title>Reviewer comments</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2017-016736.reviewer_comments.pdf"/></supplementary-material><supplementary-material id="d35e432" content-type="local-data"><caption><title>Author's manuscript</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2017-016736.draft_revisions.pdf"/></supplementary-material></sec></body><back><ack><p>We thank all the investigators and patients of the CRISTAL trial. We would like to thank Cendrine Chaffaut of the Biostatistic Team, Saint Louis Hospital for her technical assistance.</p></ack><fn-group><fn fn-type="other"><p><bold>Contributors:</bold> NH, SC and DA were involved in study concept and design. NH, SE, SJ, ASD, JC, XF, AK, JLT, JF, NA, MD and CM acquired the data; SC was involved in statistical analysis; NH, SC and DA were involved in analysis and interpretation of data; NH and DA drafted the manuscript; all authors critically revised the manuscript for important intellectual content; DA was involved in study supervision; all authors read and approved the final manuscript.</p></fn><fn fn-type="other"><p><bold>Funding:</bold> The CRISTAL study was funded by 2001 and 2010 grants (AOM 01 020) from the French Ministry of Health.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> None declared.</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> Committee for the Protection of People of Saint-Germain-en-Laye for French sites and at institutional review boards elsewhere.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Data sharing statement:</bold> Individual data are available by contacting DA at djillali.annane@aphp.fr.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Myburgh</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Mythen</surname><given-names>MG</given-names></name></person-group>
<article-title>Resuscitation fluids</article-title>. <source>N Engl J Med</source>
<year>2013</year>;<volume>369</volume>:<fpage>1243</fpage>&#x02013;<lpage>51</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMra1208627">doi:10.1056/NEJMra1208627</ext-link>
<pub-id pub-id-type="pmid">24066745</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Guyton</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>JE</given-names></name></person-group>
<source>Textbook Of Medical Physiology</source>. <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Saunders</publisher-name>, <year>2005</year>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Myburgh</surname><given-names>JA</given-names></name></person-group>
<article-title>Fluid resuscitation in acute medicine: what is the current situation?</article-title>
<source>J Intern Med</source>
<year>2015</year>;<volume>277</volume>:<fpage>58</fpage>&#x02013;<lpage>68</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/joim.12326">doi:10.1111/joim.12326</ext-link>
<pub-id pub-id-type="pmid">25352314</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Scheingraber</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rehm</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sehmisch</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery</article-title>. <source>Anesthesiology</source>
<year>1999</year>;<volume>90</volume>:<fpage>1265</fpage>&#x02013;<lpage>70</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/00000542-199905000-00007">doi:10.1097/00000542-199905000-00007</ext-link>
<pub-id pub-id-type="pmid">10319771</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Orbegozo Cort&#x000e9;s</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rayo Bonor</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>JL</given-names></name></person-group>
<article-title>Isotonic crystalloid solutions: a structured review of the literature</article-title>. <source>Br J Anaesth</source>
<year>2014</year>;<volume>112</volume>:<fpage>968</fpage>&#x02013;<lpage>81</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bja/aeu047">doi:10.1093/bja/aeu047</ext-link>
<pub-id pub-id-type="pmid">24736393</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yunos</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Bellomo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hegarty</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults</article-title>. <source>JAMA</source>
<year>2012</year>;<volume>308</volume>:<fpage>1566</fpage>&#x02013;<lpage>72</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jama.2012.13356">doi:10.1001/jama.2012.13356</ext-link>
<pub-id pub-id-type="pmid">23073953</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Verheij</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van Lingen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Beishuizen</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery</article-title>. <source>Intensive Care Med</source>
<year>2006</year>;<volume>32</volume>:<fpage>1030</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00134-006-0195-5">doi:10.1007/s00134-006-0195-5</ext-link>
<pub-id pub-id-type="pmid">16791665</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Trof</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Sukul</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Twisk</surname><given-names>JW</given-names></name>, <etal>et al</etal></person-group>
<article-title>Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia</article-title>. <source>Intensive Care Med</source>
<year>2010</year>;<volume>36</volume>:<fpage>697</fpage>&#x02013;<lpage>701</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00134-010-1776-x">doi:10.1007/s00134-010-1776-x</ext-link>
<pub-id pub-id-type="pmid">20165941</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wiedermann</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Bellomo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Perner</surname><given-names>A</given-names></name></person-group>
<article-title>Is the literature inconclusive about the harm from HES? No</article-title>. <source>Intensive Care Med</source>
<year>2016</year> (<comment>Published Online First: 23 March 2016</comment>). <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00134-016-4275-x">doi:10.1007/s00134-016-4275-x</ext-link>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ertmer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Annane</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Van Der Linden</surname><given-names>P</given-names></name></person-group>
<article-title>Is the literature inconclusive about the harm from HES? Yes</article-title>. <source>Intensive Care Med</source>
<year>2016</year> (<comment>Published Online First: 23 March 2016</comment>). <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00134-016-4278-7">doi:10.1007/s00134-016-4278-7</ext-link>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schetz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>J-L</given-names></name></person-group>
<article-title>Is the literature inconclusive about the harm of HES? We are not sure</article-title>. <source>Intensive Care Med</source>;<volume>120</volume>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00134-016-4329-0">doi:10.1007/s00134-016-4329-0</ext-link>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Perner</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Haase</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Guttormsen</surname><given-names>AB</given-names></name>, <etal>et al</etal></person-group>
<article-title>Hydroxyethyl starch 130/0.42 versus Ringer&#x02019;s acetate in severe sepsis</article-title>. <source>N Engl J Med</source>
<year>2012</year>;<volume>367</volume>:<fpage>124</fpage>&#x02013;<lpage>34</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1204242">doi:10.1056/NEJMoa1204242</ext-link>
<pub-id pub-id-type="pmid">22738085</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Myburgh</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Finfer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bellomo</surname><given-names>R</given-names></name>, <etal>et al</etal></person-group>
<article-title>Hydroxyethyl starch or saline for fluid resuscitation in intensive care</article-title>. <source>N Engl J Med</source>
<year>2012</year>;<volume>367</volume>:<fpage>1901</fpage>&#x02013;<lpage>11</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1209759">doi:10.1056/NEJMoa1209759</ext-link>
<pub-id pub-id-type="pmid">23075127</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Finfer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bellomo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Boyce</surname><given-names>N</given-names></name>, <etal>et al</etal></person-group>
<article-title>A comparison of albumin and saline for fluid resuscitation in the intensive care unit</article-title>. <source>N Engl J Med</source>
<year>2004</year>;<volume>350</volume>:<fpage>2247</fpage>&#x02013;<lpage>56</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa040232">doi:10.1056/NEJMoa040232</ext-link>
<pub-id pub-id-type="pmid">15163774</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Caironi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tognoni</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Masson</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Albumin replacement in patients with severe sepsis or septic shock</article-title>. <source>N Engl J Med</source>
<year>2014</year>;<volume>370</volume>:<fpage>1412</fpage>&#x02013;<lpage>21</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1305727">doi:10.1056/NEJMoa1305727</ext-link>
<pub-id pub-id-type="pmid">24635772</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brunkhorst</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Engel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bloos</surname><given-names>F</given-names></name>, <etal>et al</etal></person-group>
<article-title>Intensive insulin therapy and pentastarch resuscitation in severe sepsis</article-title>. <source>N Engl J Med</source>
<year>2008</year>;<volume>358</volume>:<fpage>125</fpage>&#x02013;<lpage>39</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa070716">doi:10.1056/NEJMoa070716</ext-link>
<pub-id pub-id-type="pmid">18184958</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Annane</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Siami</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jaber</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial</article-title>. <source>JAMA</source>
<year>2013</year>;<volume>310</volume>:<fpage>1809</fpage>&#x02013;<lpage>17</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jama.2013.280502">doi:10.1001/jama.2013.280502</ext-link>
<pub-id pub-id-type="pmid">24108515</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vincent</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Pinsky</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Sprung</surname><given-names>CL</given-names></name>, <etal>et al</etal></person-group>
<article-title>The pulmonary artery catheter: in medio virtus</article-title>. <source>Crit Care Med</source>
<year>2008</year>;<volume>36</volume>:<fpage>3093</fpage>&#x02013;<lpage>6</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/CCM.0b013e31818c10c7">doi:10.1097/CCM.0b013e31818c10c7</ext-link>
<pub-id pub-id-type="pmid">18824901</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>McCabe</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>GG</given-names></name></person-group>, <article-title>Gram-negative bacteremia: I. Etiology and ecology</article-title>. <source>Arch Intern Med</source>
<year>1962</year>;<volume>110</volume>:<fpage>847</fpage>&#x02013;<lpage>55</lpage>.</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Knaus</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Zimmerman</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>DP</given-names></name>, <etal>et al</etal></person-group>
<article-title>APACHE-acute physiology and chronic health evaluation: a physiologically based classification system</article-title>. <source>Crit Care Med</source>
<year>1981</year>;<volume>9</volume>:<fpage>591</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/00003246-198108000-00008">doi:10.1097/00003246-198108000-00008</ext-link>
<pub-id pub-id-type="pmid">7261642</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Teasdale</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Jennett</surname><given-names>B</given-names></name></person-group>
<article-title>Assessment of coma and impaired consciousness. A practical scale</article-title>. <source>Lancet</source>
<year>1974</year>;<volume>2</volume>:<fpage>81</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">4136544</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Le Gall</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Lemeshow</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Saulnier</surname><given-names>F</given-names></name></person-group>
<article-title>A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study</article-title>. <source>JAMA</source>
<year>1993</year>;<volume>270</volume>:<fpage>2957</fpage>&#x02013;<lpage>63</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jama.1993.03510240069035">doi:10.1001/jama.1993.03510240069035</ext-link>
<pub-id pub-id-type="pmid">8254858</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vincent</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Takala</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine</article-title>. <source>Intensive Care Med</source>
<year>1996</year>;<volume>22</volume>:<fpage>707</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">8844239</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dellinger</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Rhodes</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012</article-title>. <source>Crit Care Med</source>
<year>2013</year>;<volume>41</volume>:<fpage>580</fpage>&#x02013;<lpage>637</lpage>.<pub-id pub-id-type="pmid">23353941</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Laird</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Ware</surname><given-names>JH</given-names></name></person-group>
<article-title>Random-effects models for longitudinal data</article-title>. <source>Biometrics</source>
<year>1982</year>;<volume>38</volume>:<fpage>963</fpage>&#x02013;<lpage>74</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2307/2529876">doi:10.2307/2529876</ext-link>
<pub-id pub-id-type="pmid">7168798</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dellinger</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Rhodes</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012</article-title>. <source>Crit Care Med</source>
<year>2013</year>;<volume>41</volume>:<fpage>580</fpage>&#x02013;<lpage>637</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/CCM.0b013e31827e83af">doi:10.1097/CCM.0b013e31827e83af</ext-link>
<pub-id pub-id-type="pmid">23353941</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mann</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Zipes</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Libby</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>Braunwald&#x02019;s heart disease: a textbook of cardiovascular medicine</article-title>. <source>Elsevier Health Sciences</source>
<year>2014</year>.</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Shelhamer</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Natanson</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis</article-title>. <source>Crit Care Med</source>
<year>1987</year>;<volume>15</volume>:<fpage>923</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">3652707</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sander</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Welters</surname><given-names>ID</given-names></name>, <name name-style="western"><surname>Fo&#x000eb;x</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications</article-title>. <source>Crit Care Med</source>
<year>2005</year>;<volume>33</volume>:<fpage>81</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/01.CCM.0000150028.64264.14">doi:10.1097/01.CCM.0000150028.64264.14</ext-link>
<pub-id pub-id-type="pmid">15644652</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Orbegozo Cort&#x000e9;s</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gamarano Barros</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Njimi</surname><given-names>H</given-names></name>, <etal>et al</etal></person-group>
<article-title>Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression</article-title>. <source>Anesth Analg</source>
<year>2015</year>;<volume>120</volume>:<fpage>389</fpage>&#x02013;<lpage>402</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1213/ANE.0000000000000564">doi:10.1213/ANE.0000000000000564</ext-link>
<pub-id pub-id-type="pmid">25565318</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wiedemann</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Wheeler</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Bernard</surname><given-names>GR</given-names></name>, <etal>et al</etal></person-group>
<article-title>Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP. Comparison of two fluid-management strategies in acute lung injury</article-title>. <source>N Engl J Med</source>
<year>2006</year>;<volume>354</volume>:<fpage>2564</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">16714767</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Malbrain</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Marik</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Witters</surname><given-names>I</given-names></name>, <etal>et al</etal></person-group>
<article-title>Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice</article-title>. <source>Anaesthesiol Intensive Ther</source>
<year>2014</year>;<volume>46</volume>:<fpage>361</fpage>&#x02013;<lpage>80</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5603/AIT.2014.0060">doi:10.5603/AIT.2014.0060</ext-link>
<pub-id pub-id-type="pmid">25432556</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Boyd</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Forbes</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Nakada</surname><given-names>TA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality</article-title>. <source>Crit Care Med</source>
<year>2011</year>;<volume>39</volume>:<fpage>259</fpage>&#x02013;<lpage>65</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/CCM.0b013e3181feeb15">doi:10.1097/CCM.0b013e3181feeb15</ext-link>
<pub-id pub-id-type="pmid">20975548</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="web">
<collab>US Food and Drug Administration</collab>. <article-title>Hydroxyethyl starch solutions: FDA safety communication - boxed warning on increased mortality and severe renal injury and risk of bleeding</article-title>. <uri xlink:href="http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm358349.htm">http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm358349.htm</uri> (<comment>accessed 7 Apr 2015</comment>).</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="web">
<collab>European Medicines Agency</collab>. <article-title>PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients</article-title>.<year>2013</year>
<uri xlink:href="http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/10/WC500151964.pdf">http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/10/WC500151964.pdf</uri>
</mixed-citation></ref></ref-list></back></article>